Significance of mutations in the hepatitis B virus polymerase selected by nucleoside analogues and implications for controlling chronic disease

Viral Hepatitis Reviews

Volumn 4, Issue 3, 1998, Pages 167-187

  Bartholomeusz, A ^a   Schinazi, R F ^a   Locarnini, S A ^a  

^a ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

Antiviral resistance; Famciclovir; Hepatitis B virus; Lamivudine; Vaccine escape mutants; Viral polymerase

Indexed keywords

BMS 200; CLEVUDINE; DNA POLYMERASE; FAMCICLOVIR; GANCICLOVIR; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; LOBUCAVIR; NUCLEOSIDE ANALOG; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; CHRONIC DISEASE; DISEASE COURSE; ENZYME ACTIVITY; ENZYME ANALYSIS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; VIRUS MUTATION; VIRUS REPLICATION; VIRUS RESISTANCE;

EID: 0031714143     PISSN: 10817050     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (141)